Reduced activity of cortico-striatal fibres in the R6/2 mouse model of Huntington's disease

NeuroReport

Volumn 18, Issue 18, 2007, Pages 1997-2000

  Traficante, Anna ^a   Riozzi, Barbara ^a   Cannella, Milena ^a   Rampello, Liborio ^b   Squitieri, Ferdinando ^a   Battaglia, Giuseppe ^a  

^a IRCCS NEUROMED   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

BDNF; Glutamate; Huntington's disease; Microdialysis; R6 2 mouse; Striatum

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLUTAMIC ACID;

AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPOLARIZATION; ELECTROENCEPHALOGRAPHY; FEMALE; HIPPOCAMPUS; HUNTINGTON CHOREA; IMMUNOBLOTTING; MALE; MICRODIALYSIS; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; STRIATE CORTEX;

AGING; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBRAL CORTEX; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EXTRACELLULAR FLUID; FEMALE; GENE EXPRESSION REGULATION; GLUTAMIC ACID; HUNTINGTON DISEASE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRODIALYSIS; NEURAL PATHWAYS; SYNAPTIC TRANSMISSION;

EID: 36248951526     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3282f262ca     Document Type: Article

References (10)

1. Mangiarini T, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87:493-506.
2. Nicniocaill B, Haraldsson B, Hansson O, O'Connor WT, Brundin P. Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice. Eur J Neurosci 1991; 13:206-210.
3. Behrens PF, Franz P, Woodman B, Lindenberg KS, Landwehrmeyer GB. Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 2002; 125:1908-1922.
4. Beal MF. Neurochemistry and toxin models in Huntington's disease. Curr Opin Neurol 1994; 7:542-547.
5. Bruyn RP, Stoof JC. The quinolinic acid hypothesis in Huntington's chorea. J Neurol Sci 1990; 95:29-38.
6. Cepeda C, Hurst RS, Calvert CR, Hernandez-Echeagaray E, Nguyen OK, Jocoy E, et al. Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. J Neurosci 2003; 23:961-969.
7. Rebec GV, Barton SJ, Ennis MD. Dysregulation of ascorbate release in the striatum of behaving mice expressing the Huntington's disease gene. J Neurosci 2002; 22:RC202.
8. Franklin KBJ, Paxinos G. The mouse brain in stereotaxic coordinates. London: Academic; 1997.
9. Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL, et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 1997; 389:856-860.
10. Dougherty KD, Dreyfus CF, Black IB. Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury. Neurobiol Dis 2000; 7:574-585.